EUVIMEDEUVIMED entdecken
Open Access

Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation

Jan Martin Berke, Ying Tan, Sarah Sauviller iD, Dai-Tze Wu, Ke Zhang, Nádia Conceição-Neto, Alfonso Blázquez Moreno, Desheng Kong, George Kukolj, Chris Li, Ren Zhu, Isabel Nájera und 1 weitere

Journal of Virology · 2024

DOI: 10.1128/jvi.01502-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Jan Martin Berke und 12 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg, Beerse, Belgium. Hauptthemen laut MEDLINE: Antiviral Agents, Apoptosis, Gene Expression Regulation, Viral, Hepatitis B Core Antigens. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Capsid assembly is critical in the hepatitis B virus (HBV) life cycle, mediated by the viral core protein. Capsid assembly is the target for new anti-viral therapeutics known as capsid assembly modulators (CAMs) of which the CAM-aberrant (CAM-A) class induces aberrant shaped core protein structures and leads to hepatocyte cell death. This study aimed to identify the mechanism of action of CAM-A modulators leading to HBV-infected hepatocyte elimination where CAM-A-mediated hepatitis B surface antigen (HBsAg) reduction was evaluated in a stable HBV replicating cell line and in AAV-HBV-transduced C57BL/6, C57BL/6 SCID, and HBV-infected chimeric mice with humanized livers. Results showed that in vivo treatment with CAM-A modulators induced pronounced reductions in hepatitis B e antigen (HBeAg) and HBsAg, associated with a transient alanine amino transferase (ALT) increase. Both HBsAg and HBeAg reductions and ALT increase were delayed in C57BL/6 SCID and chimeric mice, suggesting that adaptive immune responses may indirectly contribute. However, CD8+ T cell depletion in transduced wild-type mice did not impact antigen reduction, indicating that CD8+ T cell responses are not essential. Transient ALT elevation in AAV-HBV-transduced mice coincided with a transient increase in endoplasmic reticulum stress and apoptosis markers, followed by detection of a proliferation marker. Microarray data revealed antigen presentation pathway (major histocompatibility complex class I molecules) upregulation, overlapping with the apoptosis. Combination treatment with HBV-specific siRNA demonstrated that CAM-A-mediated HBsAg reduction is dependent on de novo core protein translation. To conclude, CAM-A treatment eradicates HBV-infected hepatocytes with high core protein levels through the induction of apoptosis, which can be a promising approach as part of a regimen to achieve functional cure. IMPORTANCE Treatment with hepatitis B virus (HBV) capsid assembly modulators that induce the formation of aberrant HBV core protein structures (CAM-A) leads to programmed cell death, apoptosis, of HBV-infected hepatocytes and subsequent reduction of HBV antigens, which differentiates CAM-A from other CAMs. The effect is dependent on the de novo synthesis and high levels of core protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsApoptosisGene Expression Regulation, ViralHepatitis B Core AntigensHepatitis B virusHepatocytesProtein BiosynthesisAnimalsMiceCapsidCapsid ProteinsHepatitis BHepatitis B e AntigensHepatitis B Surface AntigensMice, Inbred C57BLMice, SCIDVirus ReplicationCell LineCD8-Positive T-LymphocytesAntigen Presentation

Stichwörter der Autor:innen

apoptosiscapsid assembly modulatorhepatitis B virusproliferationtransduced and chimeric mice

Substanzen

Antiviral AgentsCapsid ProteinsHepatitis B Core AntigensHepatitis B e AntigensHepatitis B Surface Antigens

Autor:innen und Institutionen

  • Infectious Diseases Discovery, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg, Beerse, Belgium.
  • Infectious Diseases Discovery, Janssen Research and Development, Jinchuang Mansion, Pudong, Shanghai, China.
  • Infectious Diseases Biomarkers, Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg, Beerse, Belgium.
  • Infectious Diseases Discovery, Janssen Research and Development, Brisbane, California, USA.

ORCID-Profile: Sarah Sauviller

Zitieren

APA

Berke, J. M., Tan, Y., Sauviller, S., Wu, D., Zhang, K., Conceição-Neto, N., Blázquez Moreno, A., Kong, D., Kukolj, G., Li, C., Zhu, R., Nájera, I., & Pauwels, F. (2024). Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation. Journal of Virology. https://doi.org/10.1128/jvi.01502-23

Vancouver

Berke JM, Tan Y, Sauviller S, Wu D, Zhang K, Conceição-Neto N, et al. Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation. Journal of Virology. 2024. doi:10.1128/jvi.01502-23

BibTeX
@article{Berke2024,
  author = {Berke, Jan Martin and Tan, Ying and Sauviller, Sarah and Wu, Dai-Tze and Zhang, Ke and Conceição-Neto, Nádia and Blázquez Moreno, Alfonso and Kong, Desheng and Kukolj, George and Li, Chris and Zhu, Ren and Nájera, Isabel and Pauwels, Frederik},
  title = {Class A capsid assembly modulator apoptotic elimination of hepatocytes with high HBV core antigen level in vivo is dependent on de novo core protein translation},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01502-23}
}
Kostenlos starten →